← Leaderboards
Alfred Harrison Merrill
Emory University
$10,607,945
Attributed
$10,607,945
Total exposure
24
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$14,226,468 · 25
By mechanism
R01$4,890,601 · 5
U54$4,882,513 · 2
U19$3,618,523 · 1
P41$572,459 · 13
R03$143,362 · 1
T32$83,010 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Dirck L. Dillehay$244,404
- Matam Vijay-Kumar$4,492,689
Others in their field
Top investigators on “Sphingolipids”
- Yusuf Awni Hannun · Medical University Of South Carolina$30,274,744
- Timothy Tun Hla · Boston Children'S Hospital$22,231,469
- Sarah Spiegel · Virginia Commonwealth University$19,116,930
- Besim Ogretmen · Medical University Of South Carolina$18,386,608
- Julie D Saba · University Of California, San Francisco$15,245,252
- Charles E Chalfant · Va Veterans Administration Hospital$12,100,824
Research focus
SphingolipidsGrantCellsCeramidesLipid MetabolismBaseAnabolismFundingComplexPathway InteractionsSphingosineResearch PersonnelGenesMetabolismRegulationAnalogLiquid ChromatographyMolecularGene ExpressionSphinganineEnzymesAffectDihydroceramide DesaturaseChemoprevention
Grant awards (57)
Characterization of Mammalian Ceramide Synthases$317,007
R01 · FY2015 · GM · contact PI
Characterization of Mammalian Ceramide Synthases$317,007
R01 · FY2014 · GM · contact PI
Characterization of Mammalian Ceramide Synthases$305,912
R01 · FY2013 · GM · contact PI
SPHINGOLIPIDS$460,350
U54 · FY2012 · GM · contact PI
Characterization of Mammalian Ceramide Synthases$330,182
R01 · FY2012 · GM · contact PI
SPHINGOLIPIDS$451,816
U54 · FY2011 · GM · contact PI
INVESTIGATION OF 1-DEOXYDIHYDROCERAMIDE BIOSYNTHESIS BY MAMMALIAN CELLS$15,376
P41 · FY2011 · RR · contact PI
SPHINGOLIPIDS$465,052
U54 · FY2010 · GM · contact PI
Characterization of mammalian ceramide synthases$282,261
R01 · FY2010 · GM · contact PI
Chemoprevention via modulation of autophagy by sphingolipids$71,681
R03 · FY2010 · CA · contact PI
1-DEOXY-SPHINGOID BASE AND 1-DEOXYDIHYDROCER BIOSYNTHESIS IN MAMALS$17,544
P41 · FY2010 · RR · contact PI
SPHINGOLIPIDS$468,690
U54 · FY2009 · GM · contact PI
Characterization of mammalian ceramide synthases$285,112
R01 · FY2009 · GM · contact PI
Chemoprevention via modulation of autophagy by sphingolipids$71,681
R03 · FY2009 · CA · contact PI
SPHINGOLIPIDS$480,886
U54 · FY2008 · GM · contact PI
Characterization of mammalian ceramide synthases$285,112
R01 · FY2008 · GM · contact PI
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS$178,623
P41 · FY2008 · RR · contact PI
CELL SURFACE GLYCOSPHINGOLIPIDS SSEA-3 AND SSEA-4$9,401
P41 · FY2008 · RR · contact PI
SPHINGOLIPID METABOLISM IN THE RETINA$3,760
P41 · FY2008 · RR · contact PI
Core I--Sphingolipids/Glycosphingolipids$580,575
U54 · FY2007 · GM · contact PI
Characterization of mammalian ceramide synthases$296,429
R01 · FY2007 · GM · contact PI
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS$117,335
P41 · FY2007 · RR · contact PI
2006 Glycolipid & Sphingolipid Gordon Conference$15,000
R13 · FY2007 · CA · contact PI
CELL SURFACE GLYCOSPHINGOLIPIDS SSEA-3 AND SSEA-4$6,176
P41 · FY2007 · RR · contact PI
SPHINGOLIPID METABOLISM IN THE RETINA$2,470
P41 · FY2007 · RR · contact PI
Core I--Sphingolipids/Glycosphingolipids$474,817
U54 · FY2006 · GM · contact PI
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS$117,365
P41 · FY2006 · RR · contact PI
2006 Glycolipid & Sphingolipid Gordon Conference$13,000
R13 · FY2006 · CA · contact PI
CELL SURFACE GLYCOSPHINGOLIPIDS SSEA-3 AND SSEA-4$6,177
P41 · FY2006 · RR · contact PI
SPHINGOLIPID METABOLISM IN THE RETINA$6,177
P41 · FY2006 · RR · contact PI
Core I--Sphingolipids/Glycosphingolipids$461,073
U54 · FY2005 · GM
Role of Small GTPases in Muscarinic Receptor Trafficking$262,325
R01 · FY2005 · HL
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS$27,033
P41 · FY2005 · RR
CHANGES IN SPHINGOLIPID SIGNALING LIPIDS IN SPHINGOMYELINASE D TREATED CELLS$12,288
P41 · FY2005 · RR
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$838,992
U19 · FY2004 · CA
Core I--Sphingolipids/Glycosphingolipids$400,791
U54 · FY2004 · GM
CHANGES IN SPHINGOLIPID SIGNALING LIPIDS IN SPHINGOMYELINASE D TREATED CELLS$26,367
P41 · FY2004 · RR
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS$26,367
P41 · FY2004 · RR
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$814,554
U19 · FY2003 · CA
Core I--Sphingolipids/Glycosphingolipids$638,463
U54 · FY2003 · GM
MODULATION BY GROWTH FACTORS AND SIGNAL TRANSDUCTION$263,665
R01 · FY2003 · ES
STRUCTURE/FUNCTION STUDIES OF LONG-CHAIN BASES$216,787
R01 · FY2003 · GM
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$651,873
U19 · FY2002 · CA
MODULATION BY GROWTH FACTORS AND SIGNAL TRANSDUCTION$260,518
R01 · FY2002 · ES
STRUCTURE/FUNCTION STUDIES OF LONG-CHAIN BASES$216,787
R01 · FY2002 · GM
Gordon Conference on Glycolipid &Sphingolipid Biology$8,000
R13 · FY2002 · GM
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$449,728
U19 · FY2001 · CA
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$341,504
U19 · FY2001 · CA
MODULATION BY GROWTH FACTORS AND SIGNAL TRANSDUCTION$172,948
R01 · FY2001 · ES
STRUCTURE/FUNCTION STUDIES OF LONG-CHAIN BASES$129,280
R01 · FY2001 · GM
STRUCTURE/FUNCTION STUDIES OF LONG-CHAIN BASES$120,513
R01 · FY2001 · GM
MODULATION BY GROWTH FACTORS AND SIGNAL TRANSDUCTION$86,638
R01 · FY2001 · ES
NATURALLY OCCURING SHPINGOLIPIDS AND SPINGOLIPID ANALOGS$521,872
U19 · FY2000 · CA
STRUCTURE/FUNCTION STUDIES OF LONG-CHAIN BASES$252,588
R01 · FY2000 · GM
MODULATION BY GROWTH FACTORS AND SIGNAL TRANSDUCTION$252,158
R01 · FY2000 · ES
PLANT SPHINGOLIPIDS AND CARCINOGENESIS$237,372
R01 · FY2000 · CA
NUTRITIONAL SCIENCES AND HEALTH$83,010
T32 · FY2000 · DK